510(k) K790713
K790713 is an FDA 510(k) premarket notification submitted by Kent Laboratories, Inc. for the device "ANTISERUM TO HUMAN HEMOPEXIN". The FDA issued a decision of Substantially Equivalent on September 4, 1979. The device falls under product code CZX (Hemopexin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5490. Kent Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 4, 1979
- Date Received
- April 12, 1979
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Hemopexin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5490
- Review Panel
- IM
- Submission Type